New registry tracks POEM procedure for swallowing disorder

NCT ID NCT04640753

Recruiting now Disease control Sponsor: Methodist Health System Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 200 adults with achalasia who undergo a procedure called POEM (peroral endoscopic myotomy). The goal is to see if the procedure safely reduces chest pain and swallowing problems. Researchers will review past and future patient records up to 180 days after the procedure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: peroral endoscopic myotomy (POEM) procedure
What this could lead to: If successful, this study could confirm that POEM is a safe and effective long-term treatment for achalasia, helping patients swallow more easily.
What could go wrong: This is an observational registry, not a controlled trial, so results may not prove cause and effect. Some patients may not experience lasting symptom relief.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACHALASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

achalasia Esophageal Achalasia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACHALASIA

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

Methodist Dallas Medical Center
RECRUITING

Dallas, Texas, 75203, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.